Cohen & Steers Inc CNS
74.20
(0.95)
(1.26%)
as of 25 Sep
- Market cap
- $3.9B
- P/E
- 22.7×
Follow CNS
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 28.16% | 27.26% | 27.06% | 30.89% |
+8 more TTM periods Free account |
|
| 20.38% | 18.44% | 18.14% | 21.47% | ||
ROIC |
285.43% | 182.57% | 381.66% | 25.02% | |
Return on Tangible Assets |
23.99% | 22.93% | 24.04% | 98.72% | |
Average Days of Receivables |
52.81 | 58.66 | 53.58 | 46.88 | |
Free Cash Flow per Share |
1.33 | (1.32) | (2.47) | (1.84) | |
Free Cash Flow |
68.38 | (67.66) | (126.42) | (94.05) | |
Capital Expenditures |
(3.79) | (4.80) | (5.98) | (7.37) | |
Piotroski F-Score |
3.00 | 2.00 | 2.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
5.70% | (5.31%) | (10.10%) | (13.08%) | |
Accounts Receivable Turnover |
7.23 | 6.52 | 7.06 | 7.26 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.26) | (0.26) | (0.23) | (0.22) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
65.35% | 66.04% | 66.28% | 64.42% | |
Share Based Compensation of Revenue |
7.62% | 8.00% | 8.26% | 8.47% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.43 | (0.40) | (0.79) | (0.53) | |
Depreciation/Fixed assets |
0.29 | 0.29 | 0.28 | 0.27 | |
Capex/Depreciation |
(0.21) | (0.26) | (0.33) | (0.41) | |
Revenue per Share |
11.33 | 11.03 | 10.87 | 10.78 | |
Operating CF per Share |
1.40 | (1.22) | (2.35) | (1.69) | |
Capex per Share |
(0.07) | (0.09) | (0.12) | (0.14) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
28.82% | 27.47% | 27.55% | 29.73% |
Columns are period end dates